Stage IIIC Prostate Cancer AJCC v8 Recruiting Phase 1 Trials for Docetaxel (DB01248)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0109672 (Stage IIIC Prostate Cancer AJCC v8) | Recruiting | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03218826 | PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery | Treatment |